NCT00126308 - Facial Lipoatrophy Trial: Immediate Versus Deferred Injections of Poly-L-Lactic Acid for HIV Facial Lipoatrophy | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions

HIV-Associated LipodystrophyHIV Infections

Interventions

DEVICE

poly-L-lactic acid

immediate injections poly-L-lactic acid (4 bilateral treatments - 8 vials)

DEVICE

poly-L-lactic acid

delayed (24 weeks) poly-L-lactic acid injections (4 bilateral treatment - 8 vials)

Trial Locations (18)

2010

407 Doctors, Sydney

AIDS Research Initiative, Sydney

Albion Street Clinic, Sydney

Holdsworth House General Practice, Sydney

St. Vincent's Hospital, Sydney

Taylor Square Private Clinic, Sydney

2050

Royal Prince Alfred Hospital, Camperdown

2065

Royal North Shore Hospital, Sydney

2134

Dr Doong's Surgery, Burwood

2145

Westmead Hospital, Westmead

2170

Liverpool Health Service, Sydney

2217

Waratah Clinic, St. George Hospital, Sydney

4002

Queensland Health - AIDS Medical Unit, Brisbane

4101

Gladstone Road Medical Centre, Brisbane

4220

Gold Coast Sexual Health Clinic, Gold Coast

4560

Clinic 87, Nambour

5000

The Care and Prevention Programme - Adelaide University, Adelaide

6001

Royal Perth Hospital, Perth